CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma.
Luo CH, Hu LH, Liu JY, Xia L, Zhou L, Sun RH, Lin CC, Qiu X, Jiang B, Yang MY, Zhang XH, Yang XB, Chen GQ, Lu Y.
Luo CH, et al. Among authors: yang my.
Nat Commun. 2024 Dec 5;15(1):10594. doi: 10.1038/s41467-024-54354-3.
Nat Commun. 2024.
PMID: 39632829
Free PMC article.